$64.22
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 54,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Country

US

CEO

Mr. Peter Arduini

IPO date

2022

Employees

54,000

ISIN

US36266G1076

Key stats

Open

$64.22

Volume

3.11M

Market cap

$29.42B

Prev. close

$64.70

Impl / hst vl

-

Open interest

$0.00

$64.22

Day’s Range

$64.22

$58.75

52W Range

$89.77

Valuation

50
Valuation score
Fairly Valued
P/E
15.40
P/S
1.40
P/B
2.76
Current ratio
1.22
Debt / Equity
0.74
ROE
18.75%
Gross margin
38.53%
Income growth
-33.96%
FCF growth
-87.88

Aug

14

Dividends

The next payment date will be Aug 14, 2026

Div. per Share

$0.04

Div. Yield

0.05%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 11 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$82.37
The top 23 analysts forecasts that 12-month price may increase by 28.27%, with a low of $65.65 and a high of $102.90
$65.65
Low
$82.37
Avg
$102.90
High
Current price

Earnings

Q1 ‘26 revenue
$5.13B
Q1 ‘26 net income
$389.00M
Revenue
Net income
Previous EPS
-
Estimate EPS
$1.06
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply